Effectiveness of the Safe Haven Application (App) Among Undergraduates
The goal of this randomized controlled trial is to evaluate the effectiveness of the Safe Haven app in reducing mental health symptoms and enhancing mental health literacy in undergraduates at a national university in southern Taiwan. The main questions it aims to answer are: Does the Safe Haven app lead to significantly greater reductions in general psychological distress, depression, anxiety, and stress compared to standard campus care? Does the app result in greater improvements in mental health literacy…
Conditions studied
Depression, Anxiety
About this study
The goal of this randomized controlled trial is to evaluate the effectiveness of the Safe Haven app in reducing mental health symptoms and enhancing mental health literacy in undergraduates at a national university in southern Taiwan. The main questions it aims to answer are: Does the Safe Haven app lead to significantly greater reductions in general psychological distress, depression, anxiety, and stress compared to standard campus care? Does the app result in greater improvements in mental health literacy among participants? Researchers will compare an experimental group (receiving the Safe Haven app in addition to standard campus care) to a waitlist control group (receiving standard campus care only) to see if the intervention provides superior improvements in mental health outcomes over time. Participants will: Complete online assessments at three time points: baseline (T0), post-intervention (3 months, T1), and follow-up (3 months post-intervention, T2). Experimental Group: Download the Safe Haven app to complete daily mood self-monitoring and weekly assessments, and receive psychoeducational content, personalized suggestions for 3 months. Control Group: Maintain access to standard campus care and receive access to the app after the final follow-up assessment.
Interventions
- Behavioral: Safe Haven App — A Just-in-Time Adaptive Intervention (JITAI) mobile app that integrates self-monitoring, risk stratification, and tailored psychoeducation modules. The system provides real-time feedback and stepped-care support based on the user's psychological status.
Primary outcomes
- Depression, Anxiety, and Stress Symptoms (DASS-21) (Baseline, Post-intervention (Month 3), and Follow-up (Month 6))
- General Psychological Distress (CHQ-12) (Baseline, Post-intervention (Month 3), and Follow-up (Month 6))
- Mental Health Literacy (MHLS-HPG) (Baseline, Post-intervention (Month 3), and Follow-up (Month 6))
Eligibility information
Study locations
- National Cheng Kung University, Tainan, 70101 Taiwan
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.